Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Glenmark Pharmaceuticals Inc., USA recalls Ranolazine Extended-Release Tablets 1000mg

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations
Products
  • Ranolazine Extended-Release Tablets 1000mg
Where it was sold

U.S. Nationwide

Nationwide

Units affected
N/A
About this recall
Ranolazine Extended-Release Tablets 1000mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. NDC# 68462-320-60